Results 231 to 240 of about 182,433 (270)

Treatment of cirrhotic patients in the pegylated interferon era

Digestive and Liver Disease, 2004
Chronic hepatitis C is a leading cause of cirrhosis, hepatocellular carcinoma, digestive tract haemorrhage and hepatic insufficiency. The present best strategy to prevent severe complications of chronic hepatitis C is the decrease of fibrosis progression. Recently, pegylated interferon combination treatments of chronic hepatitis C have made it possibly
openaire   +2 more sources

DOSAGE REGIMEN FOR PEGYLATED INTERFERON

2023
KLADE CHRISTOPH, ZAGRIJTSCHUK OLEH, LIN KO-CHUNG   +2 more
openaire   +4 more sources

Pegylated interferon-α2a versus pegylated interferon-α2b in hepatitis C

European Journal of Gastroenterology & Hepatology, 2014
Andrea, Messori, Valeria, Fadda, Dario, Maratea, Sabrina, Trippoli, Claudio, Marinai   +4 more
openaire   +2 more sources

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)

Annals of Oncology, 2008
Claus Garbe, Reinhard Dummer, Ulrike Leiter   +2 more
exaly  

Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications

Advanced Drug Delivery Reviews, 2002
Daniel F Wyss
exaly  

Pegylated Interferons

2008
openaire   +1 more source

Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin

Gastroenterology, 2010
Andrew J Muir, Xiang Q. Lao, Keyur Patel
exaly  

Pegylated Interferons

2006
openaire   +1 more source

Allergic sensitization to pegylated interferon-α results in drug eruptions

Allergy: European Journal of Allergy and Clinical Immunology, 2015
Stephan Meller, A Erhardt
exaly  

Pegylated Interferons

2011
openaire   +1 more source